Application of BRET for studying G protein-coupled receptors

Mini-Reviews in Medicinal Chemistry

Volumn 14, Issue 5, 2014, Pages 411-425

  Kaczor, Agnieszka A ^a,b   Makarska Bialokoz, Magdalena ^c   Selent, Jana ^d   de la Fuente, Rocío A ^e   Martí Solano, Maria ^d   Castro, Marián ^e  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

^d UNIVERSITAT POMPEU FABRA   (Spain)

^e Department of Pharmacology University of Santiago de Compostela Center for Research in Molecular Medicine and Chronic Diseases ^*  (Spain)

Author keywords

BRET; G protein coupled receptor dimmers; G protein coupled receptors

Indexed keywords

BETA ARRESTIN; CYCLIC AMP; FIBROBLAST GROWTH FACTOR RECEPTOR 1; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE; G PROTEIN COUPLED RECEPTOR KINASE 5; MUSCARINIC RECEPTOR; PROTEIN TYROSINE KINASE; RGS PROTEIN;

ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CELLULAR DISTRIBUTION; DIMERIZATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; HIGH THROUGHPUT SCREENING; HUMAN; NONHUMAN; OLIGOMERIZATION; PROTEIN PROTEIN INTERACTION; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM;

ANIMALS; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER TECHNIQUES; HUMANS; MODELS, MOLECULAR; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84903696595     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/1389557514666140428113708     Document Type: Article

References (147)

1. Park, P. S.-H. Ensemble of G Protein-Coupled Receptor Active States. Curr. Med. Chem., 2012, 19, 1146-1154.
2. Muller, C. E.; Schiedel, A. C.; Baqi, Y. Allosteric Modulators of Rhodopsin-like G Protein-Coupled Receptors: Opportunities in Drug Development. Pharmacol. Ther., 2012, 135, 292-315.
3. Fredriksson, R.; Lagerstrom, M. C.; Lundin, L.-G.; Schioth, H. B. The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints. Mol. Pharmacol., 2003, 63, 1256-72.
4. Overington, J. P.; Al-Lazikani, B.; Hopkins, A. L. How Many Drug Targets Are There? Nat. Rev. Drug Discov., 2006, 5, 993-996.
5. Congreve, M.; Marshall, F. The Impact of GPCR Structures on Pharmacology and Structure-Based Drug Design. Br. J. Pharmacol., 2010, 159, 986-996.
6. Hollenstein, K.; de Graaf, C.; Bortolato, A.; Wang, M. W.; Marshall, F. H.; Stevens, R. C. Insights into the Structure of Class B GPCRs. Trends Pharmacol. Sci., 2014, 35, 12-22.
7. Wu, H.; Wang, C.; Gregory, K. J.; Han, G. W.; Cho, H. P.; Xia, Y.; Niswender, C. M.; Katritch, V.; Meiler, J.; Cherezov, V.; Conn, P. J.; Stevens, R. C. Structure of a Class C GPCR Metabotropic Glutamate Receptor 1 Bound to an Allosteric Modulator. Science, 2014, 344, 58-64.
8. Paavola, K. J.; Hall, R. A. Adhesion G Protein-Coupled Receptors: Signaling, Pharmacology, and Mechanisms of Activation. Mol. Pharmacol., 2012, 82, 777-783.
9. Kristiansen K. Molecular Mechanisms of Ligand Binding, Signaling, and Regulation within the Superfamily of G-Protein-Coupled Receptors: Molecular Modeling and Mutagenesis Approaches to Receptor Structure and Function. Pharmacol. Ther., 2004, 103, 21-80.
10. Wang, C.; Wu, H.; Katritch, V.; Han, G. W.; Huang, X.-P.; Liu, W.; Siu, F. Y.; Roth, B. L.; Cherezov, V.; Stevens, R. C. Structure of the Human Smoothened Receptor Bound to an Antitumour Agent. Nature, 2013, 497, 338-343.
11. Audet, M.; Bouvier, M. Restructuring G-Protein-Coupled Receptor Activation. Cell 2012, 151, 14-23.
12. Venkatakrishnan, A.J.; Deupi, X.; Lebon, G.; Tate, C.G.; Schertler, G.F.; Babu, M. M. Molecular Signatures of G-Protein-Coupled Receptors. Nature, 2013, 494, 185-194.
13. Hollenstein, K.; Kean, J.; Bortolato, A.; Cheng, R. K. Y.; Dore, A. S.; Jazayeri, A.; Cooke, R. M.; Weir, M.; Marshall, F. H. Structure of Class B GPCR Corticotropin-Releasing Factor Receptor 1. Nature, 2013, 499, 438-443.
14. Rasmussen, S.; De Vree, B.; Zou, Y. Crystal Structure of the ß2 Adrenergic Receptor-Gs Protein Complex. Nature, 2011, 477, 549-555.
15. Whorton, M. R.; Bokoch, M. P.; Rasmussen, S. G. F.; Huang, B.; Zare, R. N.; Kobilka, B.; Sunahara, R. K. A Monomeric G Protein-Coupled Receptor Isolated in a High-Density Lipoprotein Particle Efficiently Activates Its G Protein. Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 7682-7687.
16. Whorton, M. R.; Jastrzebska, B.; Park, P. S.-H.; Fotiadis, D.; Engel, A.; Palczewski, K.; Sunahara, R. K. Efficient Coupling of Transducin to Monomeric Rhodopsin in a Phospholipid Bilayer. J. Biol. Chem., 2008, 283, 4387-4394.
17. Kuszak, A. J.; Pitchiaya, S.; Anand, J. P.; Mosberg, H. I.; Walter, N. G.; Sunahara, R. K. Purification and Functional Reconstitution of Monomeric Mu-Opioid Receptors: Allosteric Modulation of Agonist Binding by Gi2. J. Biol. Chem., 2009, 284, 26732-26741.
18. Bayburt, T. H.; Vishnivetskiy, S. A.; McLean, M. A.; Morizumi, T.; Huang, C.-C.; Tesmer, J. J. G.; Ernst, O. P.; Sligar, S. G.; Gurevich, V. V. Monomeric Rhodopsin Is Sufficient for Normal Rhodopsin Kinase (GRK1) Phosphorylation and Arrestin-1 Binding. J. Biol. Chem., 2011, 286, 1420-1428.
19. Damian, M.; Marie, J.; Leyris, J.-P.; Fehrentz, J.-A.; Verdie, P.; Martinez, J.; Baneres, J.-L.; Mary, S. High Constitutive Activity Is an Intrinsic Feature of Ghrelin Receptor Protein: A Study with a Functional Monomeric GHS-R1a Receptor Reconstituted in Lipid Discs. J. Biol. Chem., 2012, 287, 3630-3641.
20. Huang, J.; Chen, S.; Zhang, J. J.; Huang, X.-Y. Crystal Structure of Oligomeric ß1-Adrenergic G Protein-Coupled Receptors in Ligand-Free Basal State. Nat. Struct. Mol. Biol., 2013, 20, 419-425.
21. Milligan, G. The Role of Dimerisation in the Cellular Trafficking of G-Protein-Coupled Receptors. Curr. Opin. Pharmacol., 2010, 10, 23-29.
22. Han, Y.; Moreira, I. S.; Urizar, E.; Weinstein, H.; Javitch, J. A. Allosteric Communication between Protomers of Dopamine Class A GPCR Dimers Modulates Activation. Nat. Chem. Biol., 2009, 5, 688-695.
23. Pellissier, L. P.; Barthet, G.; Gaven, F.; Cassier, E.; Trinquet, E.; Pin, J.-P.; Marin, P.; Dumuis, A.; Bockaert, J.; Baneres, J.-L.; Claeysen, S. G Protein Activation by Serotonin Type 4 Receptor Dimers: Evidence That Turning on Two Protomers is More Efficient. J. Biol. Chem., 2011, 286, 9985-9997.
24. Moreno, J. L.; Holloway, T.; Gonzalez-Maeso, J. G Protein-Coupled Receptor Heterocomplexes in Neuropsychiatric Disorders. Prog. Mol. Biol. Transl. Sci., 2013, 117, 187-205.
25. Casado, V.; Cortes, A.; Mallol, J.; Perez-Capote, K.; Ferre, S.; Lluis, C.; Franco, R.; Canela, E. I. GPCR Homomers and Heteromers: A Better Choice as Targets for Drug Development than GPCR Monomers? Pharmacol. Ther., 2009, 124, 248-257.
26. Kaczor, A. A.; Selent, J. Oligomerization of G Protein-Coupled Receptors: Biochemical and Biophysical Methods. Curr. Med. Chem., 2011, 18, 4606-4634.
27. Selent, J.; Kaczor, A. A. Oligomerization of G Protein-Coupled Receptors: Computational Methods. Curr. Med. Chem., 2011, 18, 4588-4605.
28. Fotiadis, D.; Liang, Y.; Filipek, S.; Saperstein, D. A.; Engel, A.; Palczewski, K. The G Protein-Coupled Receptor Rhodopsin in the Native Membrane. FEBS Lett., 2004, 564, 281-288.
29. Klco, J.M.; Lassere, T.B.; Baranski, T.J. C5a Receptor Oligomerization. I. Disulfide Trapping Reveals Oligomers and Potential Contact Surfaces in a G Protein-Coupled Receptor. J. Biol. Chem., 2003, 278, 35345-35353.
30. Guo, W.; Urizar, E.; Kralikova, M.; Mobarec, J. C.; Shi, L.; Filizola, M.; Javitch, J. A. Dopamine D2 Receptors Form Higher Order Oligomers at Physiological Expression Levels. EMBO J., 2008, 27, 2293-2304.
31. Park, P. S.-H.; Wells, J. W. Oligomeric Potential of the M2 Muscarinic Cholinergic Receptor. J. Neurochem., 2004, 90, 537-548.
32. Comps-Agrar, L.; Kniazeff, J.; Norskov-Lauritsen, L.; Maurel, D.; Gassmann, M.; Gregor, N.; Prezeau, L.; Bettler, B.; Durroux, T.; Trinquet, E.; Pin, J. P. The Oligomeric State Sets GABA(B) Receptor Signalling Efficacy. EMBO J., 2011, 30, 2336-2349.
33. Albizu, L.; Balestre, M.-N.; Breton, C.; Pin, J.-P.; Manning, M.; Mouillac, B.; Barberis, C.; Durroux, T. Probing the Existence of G Protein-Coupled Receptor Dimers by Positive and Negative Ligand-Dependent Cooperative Binding. Mol. Pharmacol., 2006, 70, 1783-1791.
34. Shivnaraine, R. V.; Huang, X.-P.; Seidenberg, M.; Ellis, J.; Wells, J. W. Heterotropic Cooperativity within and between Protomers of an Oligomeric M(2) Muscarinic Receptor. Biochemistry (Mosc.), 2012, 51, 4518-4540.
35. Philip, F.; Sengupta, P.; Scarlata, S. Signaling through a G Protein-Coupled Receptor and Its Corresponding G Protein Follows a Stoichiometrically Limited Model. J. Biol. Chem., 2007, 282, 19203-19216.
36. Dorsch, S.; Klotz, K.-N.; Engelhardt, S.; Lohse, M. J.; Bunemann, M. Analysis of Receptor Oligomerization by FRAP Microscopy. Nat. Methods, 2009, 6, 225-230.
37. Maurel, D.; Comps-Agrar, L.; Brock, C.; Rives, M.-L.; Bourrier, E.; Ayoub, M. A.; Bazin, H.; Tinel, N.; Durroux, T.; Prezeau, L.; Trinquet, E.; Pin, J. P. Cell-Surface Protein-Protein Interaction Analysis with Time-Resolved FRET and Snap-Tag Technologies: Application to GPCR Oligomerization. Nat. Methods, 2008, 5, 561-567.
38. Albizu, L.; Cottet, M.; Kralikova, M.; Stoev, S.; Seyer, R.; Brabet, I.; Roux, T.; Bazin, H.; Bourrier, E.; Lamarque, L.; Breton, C.; Rives, M. L.; Newman, A.; Javitch, J.; Trinquet, E.; Manning, M.; Pin, J. P.; Mouillac, B.; Durroux, T. Resolved FRET between GPCR Ligands Reveals Oligomers in Native Tissues. Nat. Chem. Biol., 2010, 6, 587-594.
39. Ayoub, M.A.; Pfleger, K.D.G. Recent Advances in Bioluminescence Resonance Energy Transfer Technologies to Study GPCR Heteromerization. Curr. Opin. Pharmacol., 2010, 10, 44-52.
40. Breton, B.; Lagace, M.; Bouvier, M. Combining Resonance Energy Transfer Methods Reveals a Complex between the alpha2AAdrenergic Receptor, Galphai1beta1gamma2, and GRK2. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol., 2010, 24, 4733-4743.
41. Lohse, M.J.; Nuber, S.; Hoffmann, C. Fluorescence/ bioluminescence Resonance Energy Transfer Techniques to Study G-Protein-Coupled Receptor Activation and Signaling. Pharmacol. Rev., 2012, 64, 299-336.
42. Salahpour, A.; Espinoza, S.; Masri, B.; Lam, V.; Barak, L. S.; Gainetdinov, R. R. BRET Biosensors to Study GPCR Biology, Pharmacology, and Signal Transduction. Front. Endocrinol., 2012, 3, 105.
43. Alvarez-Curto, E.; Pediani, J. D.; Milligan, G. Applications of Fluorescence and Bioluminescence Resonance Energy Transfer to Drug Discovery at G Protein Coupled Receptors. Anal. Bioanal. Chem., 2010, 398, 167-180.
44. De, A. The New Era of Bioluminescence Resonance Energy Transfer Technology. Curr. Pharm. Biotechnol., 2011, 12, 558-568.
45. Milligan, G. Applications of Bioluminescence-and Fluorescence Resonance Energy Transfer to Drug Discovery at G Protein-Coupled Receptors. Eur. J. Pharm. Sci., 2004, 21, 397-405.
46. Forster, V. Zwischenmolekulare Energiewanderung und Fluoreszenz. Ann Phys. 1948, 6, 54-75.
47. Valeur, B.; Berberan-Santos, M.N. Molecular Fluorescence. Principles and Applications, second ed., WILEY-VCH Verlag GmbH&Co. KGaA, 2012.
48. Albani, J.R. Principles and Applications of Fluorescence Spectroscopy, first ed., Blackwell Publishing, 2007.
49. Lakowicz, J. R. Principles of Fluorescence Spectroscopy, third ed., Springer, 2006.
50. Bacart, J.; Corbel, C.; Jockers, R.; Bach, S.; Couturier, C. The BRET Technology and Its Application to Screening Assays. Biotechnol. J., 2008, 3, 311-324.
51. Xu, Y.; Piston, D. W.; Johnson, C. H. A Bioluminescence Resonance Energy Transfer (BRET) System: Application to Interacting Circadian Clock Proteins. Proc. Natl. Acad. Sci. U.S.A., 1999, 96, 151-156.
52. Angers, S.; Salahpour, A.; Joly, E.; Hilairet, S.; Chelsky, D.; Dennis, M.; Bouvier, M. Detection of Beta 2-Adrenergic Receptor Dimerization in Living Cells Using Bioluminescence Resonance Energy Transfer (BRET). Proc. Natl. Acad. Sci. U.S.A., 2000, 97, 3684-3689.
53. Mahon, M. J. pHluorin2: An Enhanced, Ratiometric, pH-Sensitive Green Florescent Protein. Adv. Biosci. Biotechnol. Print, 2011, 2, 132-137.
54. Mercier, J.-F.; Salahpour, A.; Angers, S.; Breit, A.; Bouvier, M. Quantitative Assessment of Beta 1-and Beta 2-Adrenergic Receptor Homo-and Heterodimerization by Bioluminescence Resonance Energy Transfer. J. Biol. Chem., 2002, 277, 44925-44931.
55. Hamdan, F. F.; Audet, M.; Garneau, P.; Pelletier, J.; Bouvier, M. High-Throughput Screening of G Protein-Coupled Receptor Antagonists Using a Bioluminescence Resonance Energy Transfer 1-Based Beta-arrestin2 Recruitment Assay. J. Biomol. Screen., 2005, 10, 463-475.
56. Kocan, M.; Dalrymple, M. B.; Seeber, R. M.; Feldman, B. J.; Pfleger, K. D. G. Enhanced BRET Technology for the Monitoring of Agonist-Induced and Agonist-Independent Interactions between GPCRs and B-Arrestins. Front. Endocrinol., 2010, 1(2), 1-9.
57. Dacres, H.; Michie, M.; Wang, J.; Pfleger, K. D. G.; Trowell, S. C. Effect of Enhanced Renilla Luciferase and Fluorescent Protein Variants on the Forster Distance of Bioluminescence Resonance Energy Transfer (BRET). Biochem. Biophys. Res. Commun., 2012, 425, 625-629.
58. Loening, A. M.; Fenn, T. D.; Wu, A. M.; Gambhir, S. S. Consensus Guided Mutagenesis of Renilla Luciferase Yields Enhanced Stability and Light Output. Protein Eng. Des. Sel. PEDS, 2006, 19, 391-400.
59. Dacres, H.; Wang, J.; Dumancic, M.M.; Trowell, S.C. Experimental Determination of the Forster Distance for Two Commonly Used Bioluminescent Resonance Energy Transfer Pairs. Anal. Chem., 2010, 82, 432-435.
60. Dacres, H.; Michie, M.; Trowell, S. C. Comparison of Enhanced Bioluminescence Energy Transfer Donors for Protease Biosensors. Anal. Biochem., 2012, 424, 206-210.
61. Nagai, T.; Ibata, K.; Park, E. S.; Kubota, M.; Mikoshiba, K.; Miyawaki, A. A Variant of Yellow Fluorescent Protein with Fast and Efficient Maturation for Cell-Biological Applications. Nat. Biotechnol., 2002, 20, 87-90.
62. Kocan, M.; See, H. B.; Seeber, R. M.; Eidne, K. A.; Pfleger, K. D. G. Demonstration of Improvements to the Bioluminescence Resonance Energy Transfer (BRET) Technology for the Monitoring of G Protein-Coupled Receptors in Live Cells. J. Biomol. Screen., 2008, 13, 888-898.
63. Kocan, M.; See, H. B.; Sampaio, N. G.; Eidne, K. A.; Feldman, B. J.; Pfleger, K. D. G. Agonist-Independent Interactions between Beta-Arrestins and Mutant Vasopressin Type II Receptors Associated with Nephrogenic Syndrome of Inappropriate Antidiuresis. Mol. Endocrinol. Baltim. Md., 2009, 23, 559-571.
64. Kamal, M.; Marquez, M.; Vauthier, V.; Leloire, A.; Froguel, P.; Jockers, R.; Couturier, C. Improved Donor/acceptor BRET Couples for Monitoring Beta-Arrestin Recruitment to G Protein-Coupled Receptors. Biotechnol. J., 2009, 4, 1337-1344.
65. Pfleger, K. D. G.; Dromey, J. R.; Dalrymple, M. B.; Lim, E. M. L.; Thomas, W. G.; Eidne, K. A. Extended Bioluminescence Resonance Energy Transfer (eBRET) for Monitoring Prolonged Protein-Protein Interactions in Live Cells. Cell. Signal., 2006, 18, 1664-1670.
66. Grossmann, C.; Ruhs, S.; Langenbruch, L.; Mildenberger, S.; Stratz, N.; Schumann, K.; Gekle, M. Nuclear Shuttling Precedes Dimerization in Mineralocorticoid Receptor Signaling. Chem. Biol., 2012, 19, 742-751.
67. Hoshino, H.; Nakajima, Y.; Ohmiya, Y. Luciferase-YFP Fusion Tag with Enhanced Emission for Single-Cell Luminescence Imaging. Nat. Methods, 2007, 4, 637-639.
68. De, A.; Ray, P.; Loening, A. M.; Gambhir, S. S. BRET3: A Red-Shifted Bioluminescence Resonance Energy Transfer (BRET)-Based Integrated Platform for Imaging Protein-Protein Interactions from Single Live Cells and Living Animals. FASEB J., 2009, 23, 2702-2709.
69. Shaner, N.C.; Campbell, R.E.; Steinbach, P.A.; Giepmans, B.N.G.; Palmer, A.E.; Tsien, R.Y. Improved Monomeric Red, Orange and Yellow Fluorescent Proteins Derived from Discosoma Sp. Red Fluorescent Protein. Nat. Biotechnol., 2004, 22, 1567-1572.
70. Dragulescu-Andrasi, A.; Chan, C.T.; De, A.; Massoud, T.F.; Gambhir, S.S. Bioluminescence Resonance Energy Transfer (BRET) Imaging of Protein-Protein Interactions within Deep Tissues of Living Subjects. Proc. Natl. Acad. Sci. U.S.A., 2011, 108, 12060-12605.
71. Loening, A.M.; Wu, A.M.; Gambhir, S.S. Red-Shifted Renilla reniformis Luciferase Variants for Imaging in Living Subjects. Nat. Methods, 2007, 4, 641-643.
72. Shcherbo, D.; Merzlyak, E.M.; Chepurnykh, T.V.; Fradkov, A. F.; Ermakova, G.V.; Solovieva, E.A.; Lukyanov, K.A.; Bogdanova, E. A.; Zaraisky, A. G.; Lukyanov, S.; Chudakov, D. M. Bright Far-Red Fluorescent Protein for Whole-Body Imaging. Nat. Methods, 2007, 4, 741-746.
73. Inouye, S.; Shimomura, O. The Use of Renilla luciferase, Oplophorus luciferase, and Apoaequorin as Bioluminescent Reporter Protein in the Presence of Coelenterazine Analogues as Substrate. Biochem. Biophys. Res. Commun., 1997, 233, 349-353.
74. Loening, A. M.; Dragulescu-Andrasi, A.; Gambhir, S. S. A Red-Shifted Renilla luciferase for Transient Reporter-Gene Expression. Nat. Methods, 2010, 7, 5-6.
75. Saito, K.; Hatsugai, N.; Horikawa, K.; Kobayashi, K.; Matsu-Ura, T.; Mikoshiba, K.; Nagai, T. Auto-Luminescent Genetically-Encoded Ratiometric Indicator for Real-Time Ca2+ Imaging at the Single Cell Level. PloS One, 2010, 5, e9935.
76. Drobac, E.; Tricoire, L.; Chaffotte, A.-F.; Guiot, E.; Lambolez, B. Calcium Imaging in Single Neurons from Brain Slices Using Bioluminescent Reporters. J. Neurosci. Res., 2010, 88, 695-711.
77. Bakayan, A.; Vaquero, C. F.; Picazo, F.; Llopis, J. Red Fluorescent Protein-Aequorin Fusions as Improved Bioluminescent Ca2+ Reporters in Single Cells and Mice. PloS One, 2011, 6, e19520.
78. Misawa, N.; Kafi, A. K. M.; Hattori, M.; Miura, K.; Masuda, K.; Ozawa, T. 2010. Rapid and High-Sensitivity Cell-Based Assays of Protein-Protein Interactions Using Split Click Beetle Luciferase Complementation: an Approach to the Study of G-Protein-Coupled Receptors. Anal. Chem., 2010, 82, 2552-2560.
79. Takakura, H.; Hattori, M.; Takeuchi, M.; Ozawa, T. Visualization and Quantitative Analysis of G Protein-Coupled Receptor-ß-Arrestin Interaction in Single Cells and Specific Organs of Living Mice Using Split Luciferase Complementation. ACS Chem. Biol., 2012, 7, 901-910.
80. Paulmurugan, R.; Umezawa, Y.; Gambhir, S. S. Noninvasive Imaging of Protein-Protein Interactions in Living Subjects by Using Reporter Protein Complementation and Reconstitution Strategies. Proc. Natl. Acad. Sci. U.S.A., 2002, 99, 15608-15613.
81. Lam, M. H. Y.; Stagljar, I. Strategies for Membrane Interaction Proteomics: No Mass Spectrometry Required. Proteomics, 2012, 12, 1519-1526.
82. Klenerman, D.; Korchev, Y.E.; Davis, S.J. Imaging and Characterisation of the Surface of Live Cells. Curr. Opin. Chem. Biol., 2011, 15, 696-703.
83. Brea, J.; Castro, M.; Giraldo, J.; Lopez-Gimenez, J. F.; Padin, J. F.; Quintian, F.; Cadavid, M. I.; Vilaro, M. T.; Mengod, G.; Berg, K. A.; Clarke, W. P.; Vilardaga, J. P.; Milligan, G.; Loza, M. I. Evidence for Distinct Antagonist-Revealed Functional States of 5-hydroxytryptamine(2A) Receptor Homodimers. Mol. Pharmacol., 2009, 75, 1380-1391.
84. White, J. H.; Wise, A.; Main, M. J.; Green, A.; Fraser, N. J.; Disney, G. H.; Barnes, A. A.; Emson, P.; Foord, S. M.; Marshall, F. H. Heterodimerization Is Required for the Formation of a Functional GABA(B) Receptor. Nature, 1998, 396, 679-682.
85. Jones, K. A.; Borowsky, B.; Tamm, J. A.; Craig, D. A.; Durkin, M. M.; Dai, M.; Yao, W. J.; Johnson, M.; Gunwaldsen, C.; Huang, L. Y.; Tang, C.; Shen, Q.; Salon, J. A.; Morse, K.; Laz, T.; Smith, K. E.; Nagarathnam, D.; Noble, S. A.; Branchek, T. A.; Gerald, C. GABA(B) Receptors Function as a Heteromeric Assembly of the Subunits GABA(B)R1 and GABA(B)R2. Nature, 1998, 396, 674-679.
86. Cottet, M.; Faklaris, O.; Maurel, D.; Scholler, P.; Doumazane, E.; Trinquet, E.; Pin, J.-P.; Durroux, T. BRET and Time-Resolved FRET Strategy to Study GPCR Oligomerization: From Cell Lines toward Native Tissues. Front. Endocrinol., 2012, 3, 1-14.
87. Suzuki, T.; Namba, K.; Mizuno, N.; Nakata, H. Hetero-Oligomerization and Specificity Changes of G Protein-Coupled Purinergic Receptors: Novel Insight into Diversification of Signal Transduction. Methods Enzymol., 2013, 521, 239-257.
88. Ayoub, M. A.; Levoye, A.; Delagrange, P.; Jockers, R. Preferential Formation of MT1/MT2 Melatonin Receptor Heterodimers with Distinct Ligand Interaction Properties Compared with MT2 Homodimers. Mol. Pharmacol., 2004, 66, 312-321.
89. Fung, J. J.; Deupi, X.; Pardo, L.; Yao, X. J.; Velez-Ruiz, G. A.; Devree, B. T.; Sunahara, R. K.; Kobilka, B. K. Ligand-Regulated Oligomerization of beta(2)-Adrenoceptors in a Model Lipid Bilayer. EMBO J., 2009, 28, 3315-3328.
90. Berthouze, M.; Rivail, L.; Lucas, A.; Ayoub, M. A.; Russo, O.; Sicsic, S.; Fischmeister, R.; Berque-Bestel, I.; Jockers, R.; Lezoualc'h, F. Two Transmembrane Cys Residues Are Involved in 5-HT4 Receptor Dimerization. Biochem.Biophys. Res. Commun., 2007, 356, 642-647.
91. McMillin, S. M.; Heusel, M.; Liu, T.; Costanzi, S.; Wess, J. Structural Basis of M3 Muscarinic Receptor Dimer/oligomer Formation. J. Biol. Chem., 2011, 286, 28584-28598.
92. Hu, J.; Hu, K.; Liu, T.; Stern, M. K.; Mistry, R.; Challiss, R. A. J.; Costanzi, S.; Wess, J. Novel Structural and Functional Insights into M3 Muscarinic Receptor Dimer/Oligomer Formation. J. Biol. Chem., 2013, 288, 34777-34790.
93. Guo, W.; Shi, L.; Filizola, M.; Weinstein, H.; Javitch, J. A. Crosstalk in G Protein-Coupled Receptors: Changes at the Transmembrane Homodimer Interface Determine Activation. Proc. Natl. Acad. Sci. U.S.A., 2005, 102, 17495-17500.
94. Harikumar, K. G.; Dong, M.; Cheng, Z.; Pinon, D. I.; Lybrand, T. P.; Miller, L. J. Transmembrane Segment Peptides Can Disrupt Cholecystokinin Receptor Oligomerization without Affecting Receptor Function. Biochemistry (Mosc.), 2006, 45, 14706-14716.
95. Gao, F.; Harikumar, K. G.; Dong, M.; Lam, P. C.-H.; Sexton, P. M.; Christopoulos, A.; Bordner, A.; Abagyan, R.; Miller, L. J. Functional Importance of a Structurally Distinct Homodimeric Complex of the Family B G Protein-Coupled Secretin Receptor. Mol. Pharmacol., 2009, 76, 264-274.
96. Harikumar, K. G.; Ball, A. M.; Sexton, P. M.; Miller, L. J. Importance of Lipid-Exposed Residues in Transmembrane Segment Four for Family B Calcitonin Receptor Homo-Dimerization. Regul. Pept., 2010, 164, 113-119.
97. Harikumar, K. G.; Morfis, M. M.; Sexton, P. M.; Miller, L. J. Pattern of Intra-Family Hetero-Oligomerization Involving the GProtein-Coupled Secretin Receptor. J. Mol. Neurosci., 2008, 36, 279-285.
98. Yu, R.; Guo, X.; Zhong, J.; Li, M.; Zeng, Z.; Zhang, H. The NTerminal HSDCIF Motif Is Required for Cell Surface Trafficking and Dimerization of Family B G Protein Coupled Receptor PAC1. PloS One, 2012, 7, e51811.
99. Roed, S. N.; Orgaard, A.; Jorgensen, R.; Meyts, P. De. Receptor Oligomerization in Family B1 of G-Protein-Coupled Receptors: Focus on BRET Investigations and the Link between GPCR Oligomerization and Binding Cooperativity. Front. Endocrinol., 2012, 3, 1-13.
100. Ng, S.Y.L.; Lee, L.T.O.; Chow, B.K.C. Receptor Oligomerization: From Early Evidence to Current Understanding in Class B GPCRs. Front. Endocrinol., 2012, 3, 1-11.
101. Kniazeff, J.; Prezeau, L.; Rondard, P.; Pin, J.-P.; Goudet, C. Dimers and beyond: The Functional Puzzles of Class C GPCRs. Pharmacol. Ther., 2011, 130, 9-25.
102. Drinovec, L.; Kubale, V.; Nohr Larsen, J.; Vrecl, M. Mathematical Models for Quantitative Assessment of Bioluminescence Resonance Energy Transfer: Application to Seven Transmembrane Receptors Oligomerization. Front. Endocrinol., 2012, 3, 1-10.
103. Harding, P. J.; Attrill, H.; Boehringer, J.; Ross, S.; Wadhams, G. H.; Smith, E.; Armitage, J. P.; Watts, A. Constitutive Dimerization of the G-Protein Coupled Receptor, Neurotensin Receptor 1, Reconstituted into Phospholipid Bilayers. Biophys. J., 2009, 96, 964-973.
104. Milligan, G.; Bouvier, M. Methods to Monitor the Quaternary Structure of G Protein-Coupled Receptors. FEBS J., 2005, 272, 2914-2925.
105. Lopez-Gimenez, J. F.; Canals, M.; Pediani, J. D.; Milligan, G. The alpha1b-Adrenoceptor Exists as a Higher-Order Oligomer: Effective Oligomerization is Required for Receptor Maturation, Surface Delivery, and Function. Mol. Pharmacol., 2007, 71, 1015-1029.
106. Pisterzi, L. F.; Jansma, D. B.; Georgiou, J.; Woodside, M. J.; Chou, J. T.-C.; Angers, S.; Raicu, V.; Wells, J. W. Oligomeric Size of the m2 Muscarinic Receptor in Live Cells as Determined by Quantitative Fluorescence Resonance Energy Transfer. J. Biol. Chem., 2010, 285, 16723-16738.
107. Patowary, S.; Alvarez-Curto, E.; Xu, T.-R.; Holz, J. D.; Oliver, J. A.; Milligan, G.; Raicu, V. The Muscarinic M3 Acetylcholine Receptor Exists as Two Differently Sized Complexes at the Plasma Membrane. Biochem. J., 2013, 452, 303-312.
108. Gorinski, N.; Kowalsman, N.; Renner, U.; Wirth, A.; Reinartz, M. T.; Seifert, R.; Zeug, A.; Ponimaskin, E.; Niv, M. Y. Computational and Experimental Analysis of the Transmembrane Domain 4/5 Dimerization Interface of the Serotonin 5-HT(1A) Receptor. Mol. Pharmacol., 2012, 82, 448-463.
109. Calebiro, D.; Rieken, F.; Wagner, J.; Sungkaworn, T.; Zabel, U.; Borzi, A.; Cocucci, E.; Zurn, A.; Lohse, M. J. Single-Molecule Analysis of Fluorescently Labeled G-Protein-Coupled Receptors Reveals Complexes with Distinct Dynamics and Organization. Proc. Natl. Acad. Sci. U.S.A., 2013, 110, 743-748.
110. Achour, L.; Kamal, M.; Jockers, R.; Marullo, S. Using Quantitative BRET to Assess G Protein-Coupled Receptor Homo-and Heterodimerization. Methods Mol. Biol. Clifton N.J., 2011, 756, 183-200.
111. Kawano, K.; Yano, Y.; Omae, K.; Matsuzaki, S.; Matsuzaki, K. Stoichiometric Analysis of Oligomerization of Membrane Proteins on Living Cells Using Coiled-Coil Labeling and Spectral Imaging. Anal. Chem., 2013, 85, 3454-3461.
112. George, N.; Pick, H.; Vogel, H.; Johnsson, N.; Johnsson, K. Specific Labeling of Cell Surface Proteins with Chemically Diverse Compounds. J. Am. Chem. Soc., 2004, 126, 8896-8897.
113. Ciruela, F.; Vilardaga, J.-P.; Fernandez-Duenas, V. Lighting up Multiprotein Complexes: Lessons from GPCR Oligomerization. Trends Biotechnol., 2010, 28, 407-415.
114. Gales, C.; Rebois, R. V.; Hogue, M.; Trieu, P.; Breit, A.; Hebert, T. E.; Bouvier, M. Real-Time Monitoring of Receptor and G-Protein Interactions in Living Cells. Nat. Methods, 2005, 2, 177-184.
115. Denis, C.; Sauliere, A.; Galandrin, S.; Senard, J.-M.; Gales, C. Probing Heterotrimeric G Protein Activation: Applications to Biased Ligands. Curr. Pharm. Des., 2012, 18, 128-144.
116. Gales, C.; Durm, J. J. J. Van; Schaak, S.; Pontier, S.; Percherancier, Y.; Audet, M.; Paris, H.; Bouvier, M. Probing the Activation-Promoted Structural Rearrangements in Preassembled Receptor-G Protein Complexes. Nat. Struct. Mol. Biol., 2006, 13, 778-786.
117. Maurice, P.; Daulat, A. M.; Turecek, R.; Ivankova-Susankova, K.; Zamponi, F.; Kamal, M.; Clement, N.; Guillaume, J.-L.; Bettler, B.; Gales, C.; et al. Molecular Organization and Dynamics of the Melatonin MT_ receptor/RGS20/G(i) Protein Complex Reveal Asymmetry of Receptor Dimers for RGS and G(i) Coupling. EMBO J., 2010, 29, 3646-3659.
118. Petrin, D.; Robitaille, M.; Hebert, T. E. Real-Time BRET Assays to Measure G Protein/effector Interactions.Methods Mol. Biol. Clifton N.J., 2011, 756, 245-261.
119. Lohse, M. J. Molecular Mechanisms of Membrane Receptor Desensitization.Biochim.Biophys. Acta, 1993, 1179, 171-188.
120. Shukla, A. K.; Xiao, K.; Lefkowitz, R. J. Emerging Paradigms of B-Arrestin-Dependent Seven Transmembrane Receptor Signaling. Trends Biochem. Sci., 2011, 36, 457-469.
121. Hasbi, A.; Devost, D.; Laporte, S. A.; Zingg, H. H. Real-Time Detection of Interactions between the Human Oxytocin Receptor and G Protein-Coupled Receptor Kinase-2. Mol. Endocrinol. Baltim. Md., 2004, 18, 1277-1286.
122. Jorgensen, R.; Kubale, V.; Vrecl, M.; Schwartz, T. W.; Elling, C. E. Oxyntomodulin Differentially Affects Glucagon-like Peptide-1 Receptor Beta-Arrestin Recruitment and Signaling through Galpha(s). J. Pharmacol. Exp. Ther., 2007, 322, 148-154.
123. Jorgensen, R.; Holliday, N. D.; Hansen, J. L.; Vrecl, M.; Heding, A.; Schwartz, T. W.; Elling, C. E. Characterization of G-Protein Coupled Receptor Kinase Interaction with the Neurokinin-1 Receptor Using Bioluminescence Resonance Energy Transfer. Mol. Pharmacol. 2008, 73, 349-358.
124. Oakley, R. H.; Laporte, S. A.; Holt, J. A.; Caron, M. G.; Barak, L. S. Differential Affinities of Visual Arrestin, Beta arrestin1, and Beta arrestin2 for G Protein-Coupled Receptors Delineate Two Major Classes of Receptors. J. Biol. Chem. 2000, 275, 17201-17210.
125. Kocan, M.; Pfleger, K. D. G. Detection of GPCR/beta-Arrestin Interactions in Live Cells Using Bioluminescence Resonance Energy Transfer Technology. Methods Mol. Biol. Clifton NJ 2009, 552, 305-317.
126. Zhang, J. H.; Chung, T. D.; Oldenburg, K. R. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J. Biomol. Screen. 1999, 4, 67-73.
127. Jenkins, L.; Brea, J.; Smith, N. J.; Hudson, B. D.; Reilly, G.; Bryant, N. J.; Castro, M.; Loza, M.-I.; Milligan, G. Identification of Novel Species-Selective Agonists of the G-Protein-Coupled Receptor GPR35 That Promote Recruitment of B-Arrestin-2 and Activate Ga13. Biochem. J. 2010, 432, 451-459.
128. Kocan, M.; Pfleger, K. D. G. Study of GPCR-Protein Interactions by BRET. Methods Mol. Biol. Clifton NJ 2011, 746, 357-371.
129. Bertrand, L.; Parent, S.; Caron, M.; Legault, M.; Joly, E.; Angers, S.; Bouvier, M.; Brown, M.; Houle, B.; Menard, L. The BRET2/arrestin Assay in Stable Recombinant Cells: A Platform to Screen for Compounds That Interact with G Protein-Coupled Receptors (GPCRS). J. Recept. Signal Transduct. Res. 2002, 22, 533-541.
130. Savage, E. E.; Wootten, D.; Christopoulos, A.; Sexton, P. M.; Furness, S. G. B. A Simple Method to Generate Stable Cell Lines for the Analysis of Transient Protein-Protein Interactions. BioTechniques 2013, 54, 217-221.
131. Audet, M.; Lagace, M.; Silversides, D. W.; Bouvier, M. Protein-Protein Interactions Monitored in Cells from Transgenic Mice Using Bioluminescence Resonance Energy Transfer. FASEB J. 2010, 24, 2829-2838.
132. Borroto-Escuela, D. O.; Flajolet, M.; Agnati, L. F.; Greengard, P.; Fuxe, K. Bioluminescence Resonance Energy Transfer Methods to Study G Protein-Coupled Receptor-Receptor Tyrosine Kinase Heteroreceptor Complexes. Methods Cell Biol. 2013, 117, 141-164.
133. Borroto-Escuela, D. O.; Romero-Fernandez, W.; Garriga, P.; Ciruela, F.; Narvaez, M.; Tarakanov, A. O.; Palkovits, M.; Agnati, L. F.; Fuxe, K. G Protein-Coupled Receptor Heterodimerization in the Brain. Methods Enzymol. 2013, 521, 281-294.
134. Flajolet, M.; Wang, Z.; Futter, M.; Shen, W.; Nuangchamnong, N.; Bendor, J.; Wallach, I.; Nairn, A. C.; Surmeier, D. J.; Greengard, P. FGF Acts as a Co-Transmitter through Adenosine A(2A) Receptor to Regulate Synaptic Plasticity. Nat. Neurosci. 2008, 11, 1402-1409.
135. Borroto-Escuela, D. O.; Romero-Fernandez, W.; Mudo, G.; Perez-Alea, M.; Ciruela, F.; Tarakanov, A. O.; Narvaez, M.; Liberto, V. Di; Agnati, L. F.; Belluardo, N.; et al. Fibroblast Growth Factor Receptor 1-5-Hydroxytryptamine 1A Heteroreceptor Complexes and Their Enhancement of Hippocampal Plasticity. Biol. Psychiatry 2012, 71, 84-91.
136. Lan, T.-H.; Liu, Q.; Li, C.; Wu, G.; Lambert, N. A. Sensitive and High Resolution Localization and Tracking of Membrane Proteins in Live Cells with BRET. Traffic Cph. Den. 2012, 13, 1450-1456.
137. Chiu, V. K.; Bivona, T.; Hach, A.; Sajous, J. B.; Silletti, J.; Wiener, H.; Johnson, R. L. 2nd; Cox, A. D.; Philips, M. R. Ras Signalling on the Endoplasmic Reticulum and the Golgi. Nat Cell Biol. 2002, 4, 343-350.
138. Nishimura A1, Linder ME. Identification of a Novel Prenyl and Palmitoyl Modification at the CaaX Motif of Cdc42 that Regulates RhoGDI Binding. Mol. Cell Biol. 2013, 33, 1417-1429.
139. Vilardaga, J.-P.; Bunemann, M.; Krasel, C.; Castro, M.; Lohse, M. J. Measurement of the Millisecond Activation Switch of G Protein-Coupled Receptors in Living Cells. Nat. Biotechnol. 2003, 21, 807-812.
140. Castro, M.; Nikolaev, V. O.; Palm, D.; Lohse, M. J.; Vilardaga, J.-P.Turn-on Switch in Parathyroid Hormone Receptor by a Two-Step Parathyroid Hormone Binding Mechanism. Proc. Natl. Acad. Sci. U. S. A. 2005, 102, 16084-16089.
141. Ferrandon, S.; Feinstein, T. N.; Castro, M.; Wang, B.; Bouley, R.; Potts, J. T.; Gardella, T. J.; Vilardaga, J.-P. Sustained Cyclic AMP Production by Parathyroid Hormone Receptor Endocytosis. Nat. Chem. Biol. 2009, 5, 734-742.
142. Szalai, B.; Barkai, L.; Turu, G.; Szidonya, L.; Varnai, P.; Hunyady, L. Allosteric Interactions within the ATB Angiotensin Receptor Homodimer: Role of the Conserved DRY Motif. Biochem. Pharmacol. 2012, 84, 477-485.
143. Dacres, H.; Wang, J.; Leitch, V.; Horne, I.; Anderson, A. R.; Trowell, S. C. Greatly Enhanced Detection of a Volatile Ligand at Femtomolar Levels Using Bioluminescence Resonance Energy Transfer (BRET). Biosens. Bioelectron. 2011, 29, 119-124.
144. Jiang, L. I.; Collins, J.; Davis, R.; Lin, K.-M.; DeCamp, D.; Roach, T.; Hsueh, R.; Rebres, R. A.; Ross, E. M.; Taussig, R.; Fraser, I.: Sternweis, P. C. Use of a cAMP BRET Sensor to Characterize a Novel Regulation of cAMP by the Sphingosine 1-phosphate/G13 Pathway. J. Biol. Chem. 2007, 282, 10576-10584.
145. Barak, L. S.; Salahpour, A.; Zhang, X.; Masri, B.; Sotnikova, T. D.; Ramsey, A. J.; Violin, J. D.; Lefkowitz, R. J.; Caron, M. G.; Gainetdinov, R. R. Pharmacological Characterization of Membrane-Expressed Human Trace Amine-Associated Receptor 1 (TAAR1) by a Bioluminescence Resonance Energy Transfer cAMP Biosensor. Mol. Pharmacol. 2008, 74, 585-594.
146. Charest, P. G.; Terrillon, S.; Bouvier, M. Monitoring Agonist-Promoted Conformational Changes of Beta-Arrestin in Living Cells by Intramolecular BRET. EMBO Rep. 2005, 6, 334-340.
147. Shukla, A. K.; Violin, J. D.; Whalen, E. J.; Gesty-Palmer, D.; Shenoy, S. K.; Lefkowitz, R. J. Distinct Conformational Changes in Beta-Arrestin Report Biased Agonism at Seven-Transmembrane Receptors. Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 9988-9993.